BiolineRx buys UK co Agalimmune
BiolineRx is paying $6 million upfront for Agalimmune, which has developed a new immunotherapy solution for treating cancer.
Teva fires dozens in Israel
Many more employees will be let go in Israel and worldwide as the pharmaceutical company implements a new streamlining plan.
Intec Pharma raises $10m in private placement
The Israeli biopharma company has developed an oral drug delivery system to improve the efficacy and safety of drugs by utilizing an efficient gastric retention and release mechanism.
Debt weighs on Teva
On top of all its other woes, the Israeli pharmaceutical giant has a net debt of $35 billion, higher than its $32 billion market cap.